Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEUBASE-THERAPEUTICS-INC-61956606/news/NeuBase-Therapeutics-Inc-Presents-New-Preclinical-Data-At-ASGCT-2022-for-Its-Dm1-Program-Demonstra-40465244/?utm_source=whatsapp&utm_medium=social&utm_campaign=share